These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4943669)

  • 1. The effect of antilymphocyte serum, imuran and hydrocortisone on the development of colibacillary infection in mice.
    Hatala M; Liska M; Hasková V; Gansová E
    Folia Biol (Praha); 1971; 17(4):264-6. PubMed ID: 4943669
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of various immunosuppressive drugs on the development of experimental renal infection in rats.
    Liska M; Hatala M; Hasková V; Bednarík T
    Folia Biol (Praha); 1975; 21(3):171-5. PubMed ID: 1100444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications of immunosuppressive therapy in transplantation. 2: Specific immunosuppressive agents.
    Russ GR
    Med J Aust; 1992 Aug; 157(4):264-7. PubMed ID: 1435444
    [No Abstract]   [Full Text] [Related]  

  • 4. Complications of immunosuppression.
    Penn I
    Minerva Chir; 1971 Jul; 26(13):718-20. PubMed ID: 5567243
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of immunosuppression in the genesis and growth of malignant tumours.
    Reis HE
    Ger Med Mon; 1971; 1(1):16-21. PubMed ID: 4931500
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunosuppression and experimental tuberculosis. I. The effects of immunosuppressive agents, antilymphocyte serum and antimacrophage serum on the survival of animals with subacute experimental tuberculosis.
    Müllerová M; Nouza K; Trnka L
    Biomedicine; 1973 Mar; 19(3):87-9. PubMed ID: 4734093
    [No Abstract]   [Full Text] [Related]  

  • 7. [Reduced resistance to infection in immunosuppression and its modification through previous immunization. (Preliminary report)].
    Liska M; Hatala M
    Z Immunitatsforsch Allerg Klin Immunol; 1968 May; 135(3):278-82. PubMed ID: 4234964
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antilymphocyte serum. II].
    Bach JF
    Rev Eur Etud Clin Biol; 1970 Mar; 15(3):258-78. PubMed ID: 4986650
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chronic antigenic stimulation as a pathogenic factor in the development of malignant lymphoma].
    Myking AO
    Nord Med; 1971 May; 85(21):645-9. PubMed ID: 5581410
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of antilymphocyte globulin upon the incidence of malignancies after kidney transplantation.
    Luciani J; Benalia H; Bitker MO; Mouquet C; Chartier-Kastler E; Ourhama S; Jacobs C; Chatelain C; Viars P
    Transplant Proc; 1993 Jun; 25(3):2302. PubMed ID: 8516907
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute necrotizing gastritis by Escherichia coli in a severely neutropenic patient.
    Martínez-Chamorro C; Martínez E; Gil-Fernández JJ; Escudero A; Acevedo A; Fernández-Rañada JM
    Haematologica; 2002 Jan; 87(1):ELT01. PubMed ID: 11801485
    [No Abstract]   [Full Text] [Related]  

  • 12. Cryptococcal meningitis after Imuran (azathioprine) therapy for autoimmune hepatitis.
    Sethi NK; Torgovnick J; Sethi PK
    Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):913-4. PubMed ID: 17873619
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental model for simultaneous determination of mitostatic and lymphotoxic action of cytostatics and immunodepressants].
    Petrov RV; Man'ko VM; Khaitov RM; Seslavina LS
    Tsitologiia; 1972 Jan; 14(1):121-7. PubMed ID: 5011336
    [No Abstract]   [Full Text] [Related]  

  • 14. Myocardial changes and kidney transplantation. Lesions in patients receiving immunosuppressive therapy.
    Chatty ME; Deodhar SD
    Arch Pathol; 1969 Dec; 88(6):602-8. PubMed ID: 4982499
    [No Abstract]   [Full Text] [Related]  

  • 15. Minimizing the toxicity of antilymphocyte antibody therapy.
    Pascual M; Rubin RH; Cosimi AB
    Transplant Proc; 1996 Aug; 28(4):2113-4. PubMed ID: 8769171
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of immunosuppressive agents and antilymphocyte serum on bacterial translocation in mice].
    Anderlik P; Antmann K; Bános Z
    Acta Pharm Hung; 1999 Apr; 69(2):69-71. PubMed ID: 10389300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hazards of immunosuppressive agents in general practice].
    Godeau P; Herreman G; Sicard D; de Saxce H
    Rev Prat; 1972 Dec; 22(33):4617-24. PubMed ID: 4660110
    [No Abstract]   [Full Text] [Related]  

  • 18. Malignant lymphomas and plasmacytosis in mice under prolonged immunosuppression and persistent antigenic stimulation.
    Krueger GR; Malmgren RA; Berard CW
    Transplantation; 1971 Feb; 11(2):138-44. PubMed ID: 5578738
    [No Abstract]   [Full Text] [Related]  

  • 19. [Malignant lymphoreticular tumors neoplasms caused by immune disorders].
    Cappelaere P
    Lille Med; 1972 May; 17(5):738-48. PubMed ID: 4560302
    [No Abstract]   [Full Text] [Related]  

  • 20. Antilymphocyte serum in tissue transplantation.
    Gunn A
    Minerva Chir; 1971 Jul; 26(13):709-17. PubMed ID: 4935930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.